267 related articles for article (PubMed ID: 33228399)
1. Clinical Score Predicting Overall Survival After Surgery for Synchronous Metastatic Adrenocortical Carcinoma: A Surveillance, Epidemiology, and End Result-Based Study.
Wu K; Liu Z; Li X; Lu Y
Am Surg; 2021 May; 87(5):805-811. PubMed ID: 33228399
[TBL] [Abstract][Full Text] [Related]
2. Adrenal Surgery for Synchronously Metastatic Adrenocortical Carcinoma: A Population-Based Analysis.
Wu K; Liu Z; Li X; Lu Y
World J Surg; 2021 May; 45(5):1457-1465. PubMed ID: 33481081
[TBL] [Abstract][Full Text] [Related]
3. Surgical management of adrenocortical carcinoma.
Ranvier GG; Inabnet WB
Endocrinol Metab Clin North Am; 2015 Jun; 44(2):435-52. PubMed ID: 26038210
[TBL] [Abstract][Full Text] [Related]
4. Clinical Score Predicting Long-Term Survival after Repeat Resection for Recurrent Adrenocortical Carcinoma.
Tran TB; Maithel SK; Pawlik TM; Wang TS; Hatzaras I; Phay JE; Fields RC; Weber SM; Sicklick JK; Yopp AC; Duh QY; Solorzano CC; Votanopoulos KI; Poultsides GA
J Am Coll Surg; 2016 Dec; 223(6):794-803. PubMed ID: 27618748
[TBL] [Abstract][Full Text] [Related]
5. Surgery is associated with improved survival for adrenocortical cancer, even in metastatic disease.
Livhits M; Li N; Yeh MW; Harari A
Surgery; 2014 Dec; 156(6):1531-40; discussion 1540-1. PubMed ID: 25456949
[TBL] [Abstract][Full Text] [Related]
6. Metastatic adrenocortical carcinoma with a prolonged response to mitotane.
Pal SK; Gartrell B; Olsson CA; Stein CA
Oncology (Williston Park); 2014 Jul; 28(7):624-5, 642. PubMed ID: 25144285
[No Abstract] [Full Text] [Related]
7. Outcomes of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A 13-Institution Study by the US Adrenocortical Carcinoma Group.
Postlewait LM; Ethun CG; Tran TB; Prescott JD; Pawlik TM; Wang TS; Glenn J; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Staley CA; Poultsides GA; Maithel SK
J Am Coll Surg; 2016 Apr; 222(4):480-90. PubMed ID: 26775162
[TBL] [Abstract][Full Text] [Related]
8. A nomogram for individualized estimation of survival among adult patients with adrenocortical carcinoma after surgery: a retrospective analysis and multicenter validation study.
Kong J; Zheng J; Cai J; Wu S; Diao X; Xie W; Chen X; Liao C; Yu H; Fan X; Huang C; Liu Z; Chen W; Lv Q; Qin H; Huang J; Lin T
Cancer Commun (Lond); 2019 Nov; 39(1):80. PubMed ID: 31775884
[TBL] [Abstract][Full Text] [Related]
9. Surgical management of advanced adrenocortical carcinoma: a 21-year population-based analysis.
Tran TB; Liou D; Menon VG; Nissen NN
Am Surg; 2013 Oct; 79(10):1115-8. PubMed ID: 24160811
[TBL] [Abstract][Full Text] [Related]
10. Outcome after resection of Adrenocortical Carcinoma liver metastases: a retrospective study.
Baur J; Büntemeyer TO; Megerle F; Deutschbein T; Spitzweg C; Quinkler M; Nawroth P; Kroiss M; Germer CT; Fassnacht M; Steger U;
BMC Cancer; 2017 Aug; 17(1):522. PubMed ID: 28778197
[TBL] [Abstract][Full Text] [Related]
11. A twelve-year experience with adrenal cortical carcinoma in a single institution: long-term survival after surgical treatment and transcatheter arterial embolization.
Soga H; Takenaka A; Ooba T; Nakano Y; Miyake H; Takeda M; Tanaka K; Hara I; Fujisawa M
Urol Int; 2009; 82(2):222-6. PubMed ID: 19322014
[TBL] [Abstract][Full Text] [Related]
12. Features of synchronous versus metachronous metastasectomy in adrenal cortical carcinoma: Analysis from the US adrenocortical carcinoma database.
Prendergast KM; Smith PM; Tran TB; Postlewait LM; Maithel SK; Prescott JD; Pawlik TM; Wang TS; Glenn J; Hatzaras I; Shenoy R; Phay JE; Shirley LA; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Votanopoulos KI; Levine EA; Poultsides GA; Solórzano CC; Kiernan CM
Surgery; 2020 Feb; 167(2):352-357. PubMed ID: 31272813
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study.
Libé R; Borget I; Ronchi CL; Zaggia B; Kroiss M; Kerkhofs T; Bertherat J; Volante M; Quinkler M; Chabre O; Bala M; Tabarin A; Beuschlein F; Vezzosi D; Deutschbein T; Borson-Chazot F; Hermsen I; Stell A; Fottner C; Leboulleux S; Hahner S; Mannelli M; Berruti A; Haak H; Terzolo M; Fassnacht M; Baudin E;
Ann Oncol; 2015 Oct; 26(10):2119-25. PubMed ID: 26392430
[TBL] [Abstract][Full Text] [Related]
14. Resection of adrenocortical carcinoma liver metastasis: is it justified?
Gaujoux S; Al-Ahmadie H; Allen PJ; Gonen M; Shia J; D'Angelica M; Dematteo R; Fong Y; Blumgart L; Jarnagin WR
Ann Surg Oncol; 2012 Aug; 19(8):2643-51. PubMed ID: 22526905
[TBL] [Abstract][Full Text] [Related]
15. Outcome of operation in patients with adrenocortical cancer invading the inferior vena cava--a European Society of Endocrine Surgeons (ESES) survey.
Mihai R; Iacobone M; Makay O; Moreno P; Frilling A; Kraimps JL; Soriano A; Villar del Moral J; Barczynski M; Durán MC; Sadler GP; Niederle B; Dralle H; Harrison B; Carnaille B
Langenbecks Arch Surg; 2012 Feb; 397(2):225-31. PubMed ID: 22134748
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Outcomes of Adjuvant Mitotane Therapy in Patients With Radically Resected Adrenocortical Carcinoma.
Berruti A; Grisanti S; Pulzer A; Claps M; Daffara F; Loli P; Mannelli M; Boscaro M; Arvat E; Tiberio G; Hahner S; Zaggia B; Porpiglia F; Volante M; Fassnacht M; Terzolo M
J Clin Endocrinol Metab; 2017 Apr; 102(4):1358-1365. PubMed ID: 28324035
[TBL] [Abstract][Full Text] [Related]
17. Long-term survival after adrenalectomy for stage I/II adrenocortical carcinoma (ACC): a retrospective comparative cohort study of laparoscopic versus open approach.
Donatini G; Caiazzo R; Do Cao C; Aubert S; Zerrweck C; El-Kathib Z; Gauthier T; Leteurtre E; Wemeau JL; Vantyghem MC; Carnaille B; Pattou F
Ann Surg Oncol; 2014 Jan; 21(1):284-91. PubMed ID: 24046101
[TBL] [Abstract][Full Text] [Related]
18. Borderline resectable adrenal cortical carcinoma: a potential role for preoperative chemotherapy.
Bednarski BK; Habra MA; Phan A; Milton DR; Wood C; Vauthey N; Evans DB; Katz MH; Ng CS; Perrier ND; Lee JE; Grubbs EG
World J Surg; 2014 Jun; 38(6):1318-27. PubMed ID: 24615603
[TBL] [Abstract][Full Text] [Related]
19. Adrenal biopsy, as a diagnostic method, is associated with decreased overall survival in patients with T1/T2 adrenocortical carcinoma: A propensity score-matched analysis.
Naffouje SA; Sabesan A; Hallanger-Johnson J; Kirtane K; Gonzalez RJ; Mullinax J
J Surg Oncol; 2021 Dec; 124(8):1261-1271. PubMed ID: 34424540
[TBL] [Abstract][Full Text] [Related]
20. Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy.
Grisanti S; Cosentini D; Laganà M; Morandi A; Lazzari B; Ferrari L; Volta AD; Ambrosini R; Ferrari VD; Sigala S; Berruti A
Front Endocrinol (Lausanne); 2021; 12():624102. PubMed ID: 33716976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
